Stay updated with breaking news from Biodesix inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Essex Investment Management Co. LLC trimmed its stake in shares of Biodesix, Inc. (NASDAQ:BDSX – Free Report) by 1.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,016,313 shares of the company’s stock after selling 15,900 shares during the […]
Fortrea (NASDAQ:FTRE – Get Free Report) and Biodesix (NASDAQ:BDSX – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation. Profitability This table compares Fortrea and Biodesix’s net margins, return […]
Fortrea (NASDAQ:FTRE – Get Free Report) and Biodesix (NASDAQ:BDSX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, risk and institutional ownership. Analyst Recommendations This is a breakdown of current ratings and […]
/PRNewswire/ -- The "Next Generation Sequencing (NGS) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path...
In-Depth Analysis of Next Generation Sequencing (NGS) Tests, 2023 Clinical Pipeline Report lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) shares were up 0.5% during mid-day trading on Friday . The company traded as high as $1.99 and last traded at $1.97. Approximately 53,036 shares traded hands during mid-day trading, a decline of 36% from the average daily volume of 83,126 shares. The stock had previously closed at […]
Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) saw a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 134,100 shares, a drop of 14.7% from the November 15th total of 157,300 shares. Based on an average daily trading volume, of 67,900 shares, the short-interest ratio […]
/PRNewswire/ -- The "Proteomics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Proteomics Market to...
Equities Research Analysts’ updated eps estimates for Thursday, December 7th: AcelRx Pharmaceuticals (NASDAQ:ACRX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $5.00 target price on the stock. C3.ai (NYSE:AI) had its hold rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $27.00 […]